David M. Simpson, M.D.
David M. Simpson, MD, is currently Professor of Neurology at Icahn School of Medicine in New York, New York. In addition, he is Director of the Clinical Neurophysiology Laboratories and Director of the Neuro-AIDS Program at Mount Sinai Hospital.
Dr. Simpson received his medical degree from State University of New York (SUNY) at Buffalo School of Medicine. He completed an internship in Internal Medicine at University Hospitals of Cleveland, Case Western Reserve University in Cleveland, Ohio, and a residency in Neurology at Cornell University Medical Center in New York. He completed a fellowship in Clinical Neurophysiology at Massachusetts General Hospital, Harvard Medical School, in Boston, Massachusetts.
Dr. Simpson is a member of the American Neurological Association and the American Pain Society. He is a fellow of the American Academy of Neurology and the American Academy of Neuromuscular and Electrodiagnostic Medicine. He is on the editorial board of AIDS Patient Care, Neurology and Clinical Neurophysiology, and Current HIV/AIDS Reports, and he is an ad-hoc reviewer for Annals of Internal Medicine, Annals of Neurology, Archives of Internal Medicine, and American Journal of Medicine, among others. An author of over 300 publications, Dr. Simpson is the principal investigator for many studies, including the treatment of neuropathic pain in patients with painful HIV-associated neuropathy and treatment of spasticity with botulinum toxin.
Jessica Robinson-Papp, M.D.
Jessica Robinson-Papp, M.D. is an assistant professor of Neurology and Pathology at the Mount Sinai Medical Center in New York. She completed her neurology residency and neurophysiology fellowship at Mount Sinai Medical Center. Dr. Robinson-Papp supervises the Jack Martin Fund Neuro-AIDS Clinic and the inpatient neuro-AIDS consult service. She also maintains a clinical faculty practice in general neurology with a specialization in neuro-AIDS, neuromuscular disease, and electromyography.
Dr. Robinson-Papp's research interests include the effects of HIV on both the central and peripheral nervous systems. She is the attending neurologist for the Manhattan HIV Brain Bank, a longitudinal, organ-donation study of the neurological manifestations of HIV.
Kathryn Jane Elliott, M.D.
Kathryn Jane Elliott, M.D. is an internationally trained and board certified neurologist. Her medical degree was obtained from University of Calgary, Alberta, Canada. Her internal medicine residency training was obtained at McGill University at the Montreal General Hospital and neurology residency at the University of British Columbia, at the Vancouver General Hospital in Vancouver, Canada. She completed a Pain Fellowship in the Department of Neurology at Memorial Sloan Kettering Cancer Center where she was awarded the Clinical Scholars Award for her work in developing new models of opioid tolerance.
She was awarded a Charles A. Dana Fellowship for her work in palliative care and neuropathic pain. While at MSKCC, she developed new models of neuropathic pain and was additionally awarded 3 years of funding as a VZV Fellow from the VZV Foundation in addition to her work as a faculty member in the Neurology Department. She also became Principal Investigator of a NIDA Career development grant and a Co-Investigator on another NIDA grant evaluating models of pain and opioid tolerance.
She is the first author of the original research leading to the development of MorphiDex, a combination neuropathic pain agent (NMDA receptor antagonist dextromethorphan with morphine). She has also completed one year's advanced training in neurology and neurology trials research methods, focusing on peripheral nerve neurology, at the National Hospital of Neurology and Neurosurgery, Queen Square, London, England, which resulted in M.Sc award.
She is working with Dr. Simpson as NeuroAIDS Fellow to fulfill her longstanding goal of studying health care disparities and plans to complete training in HIV and Neuroinfections before recommencing a busy research and clinical practice. She presently sees patients at the Jack Martin Clinic and is a research neurologist for the Charter and Brain Bank studies of patients with HIV.
David Dorfman, Ph.D.
David Dorfman, Ph.D. is currently Assistant Clinical Professor of Psychiatry at Icahn School of Medicine. Dr. Dorfman received his doctorate in Psychology from New York University. His postdoctoral training was at Memorial Sloan-Kettering Cancer Center where he specialized in the neuropsychology of HIV infection.
Many of the patients in his private practice have HIV related issues. As a result, his laboratory work focuses on HIV and the nervous system and on substance use.
Mary Catherine George
Research Program Manager
Mary Catherine George has worked in the field of research for over fifteen years. She began her career in the area of HIV/AIDS research during the period when antiretroviral treatments were underdevelopment. Also, Ms. George assisted in designing and launching the first study in post-exposure-prophylaxis in HIV/AIDS in New York City. Ms. George has been instrumental in the design and implementation of numerous clinical trials, and currently is working to gain her doctoral degree in psychology (2012) to further explore research in the areas of behavior as they relate to wellbeing and chronic pain.
Lynne Bartell has over 10 years experience doing HIV/Aids research. She has done studies of new HIV and Hepatitis drug therapies, and Post HIV-exposure prophylaxis treatment at Bentley Health Care, New York. At the New York Blood Center she worked on studies of HIV vaccines and behavioral interventions to prevent HIV acquisition. She also has over 10 years experience working as a counselor on an HIV/Aids Hotline, and has a Masters Degree in Psychology.